Chondroitin-4-sulfate transferase-1 depletion inhibits formation of a proteoglycan-rich layer and alters immunotolerance of bone marrow mesenchymal stem cells on titanium oxide surfaces
Source abstract
Abstract
Successful osseointegration is essential for dental implants. However, the complete molecular mechanism of osseointegration remains to be elucidated. In this study, we focused on the proteoglycan (PG)-rich layer between titanium oxides (TiOx) and bone, and chondroitin-4-sulfate transferase-1 (C4ST-1), which forms the sugar chain in PGs. Human bone marrow mesenchymal stem cells (hBMSCs) depleted of C4ST-1 were cultured on titanium (Ti) plates, and the interface between hBMSCs and TiOx was analyzed using transmission electron microscopy. Immunotolerance, proliferation, initial adhesion, and calcification of the cells were analyzed in vitro. At 14 days of cultivation, a PG-rich layer was observed between hBMSCs and TiOx. However, the PG-rich layer was reduced in C4ST-1-depleted hBMSCs on TiOx. Real-time RT-PCR showed that conditioned media increased the levels of expression of M1-macrophage markers in human macrophages. However, depletion of C4ST-1 did not affect calcification, cell proliferation, or initial cell adhesion on Ti plates. These results suggested that C4ST-1 in hBMSCs affects their immunotolerance and alters the formation of PG-rich layer formation on TiOx.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Proteoglycans and glycosaminoglycans research · Periodontal Regeneration and Treatments · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Titanium oral implants: surface characteristics, interface biology and clinical outcome
2. Electron microscopic analysis of the bone-titanium interface10.3109/17453678308992868 ↗
3. Ultrastructural differences of the interface zone between bone and Ti 6Al 4V or commercially pure titanium10.1016/0141-5425(89)90158-1 ↗
4. Electron microscopy of bone response to titanium cylindrical screw-type endosseous dental implants
5. Light and electron microscopic studies of bone-titanium interface in the tibiae of young and mature rats10.1002/(SICI)1097-4636(199604)30:4<523::AID-JBM11>3.0.CO;2-I ↗
6. The bone-implant interface of dental implants in humans on the atomic scale10.1016/j.actbio.2016.11.044 ↗
7. Proteomic analysis of bone proteins adsorbed onto the surface of titanium dioxide
8. A role for proteoglycans in mineralized tissue-titanium adhesion10.1177/154405910708600208 ↗
9. Glycosaminoglycan and proteoglycan-based biomaterials: current trends and future perspectives10.1002/adhm.201701042 ↗
10. Adsorption of glycosaminoglycans to commercially pure titanium10.1016/0142-9612(92)90107-Y ↗
11. Glycosaminoglycan degradation reduces mineralized tissue-titanium interfacial strength10.1002/jbm.a.30624 ↗
12. Proteoglycans at the bone-implant interface10.1177/10454411980090040401 ↗
13. Hard tissue implant interface
14. Surface modification of implants in long bone10.4161/biom.21563 ↗
15. Biosynthesis and function of chondroitin sulfate10.1016/j.bbagen.2013.06.006 ↗
16. Molecular cloning and expression of chondroitin 4-sulfotransferase10.1074/jbc.275.12.8975 ↗
17. Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family10.1074/jbc.M002443200 ↗
18. Molecular cloning and characterization of chondroitin-4-O-sulfotransferase-3. A novel member of the HNK-1 family of sulfotransferases10.1074/jbc.M204907200 ↗
19. Molecular cloning and characterization of a dermatan-specific N-acetylgalactosamine 4-O-sulfotransferase10.1074/jbc.M105848200 ↗
20. Specificities of three distinct human chondroitin/dermatan N-acetylgalactosamine 4-O-sulfotransferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesis10.1074/jbc.M306044200 ↗
21. The roles of chondroitin-4-sulfotransferase-1 in development and disease10.1016/S1877-1173(10)93006-8 ↗
22. Mesenchymal stem cells in health and disease10.1038/nri2395 ↗
23. Bone-marrow-derived mesenchymal stem cells for organ repair10.1155/2013/132642 ↗
24. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
25. Monocyte and macrophage heterogeneity10.1038/nri1733 ↗
26. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide10.1186/s12885-015-1546-9 ↗
27. Electron microscopic visualization of proteoglycans with Ruthenium Red10.1007/BF01003636 ↗
28. Dermatan sulfotransferase Chst14/D4st1, but not chondroitin sulfotransferase Chst11/C4st1, regulates proliferation and neurogenesis of neural progenitor cells10.1242/jcs.088120 ↗
29. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man10.3109/17453678108991776 ↗
30. Bone-metal interface in osseointegration10.1016/0022-3913(87)90344-1 ↗
31. Experimental studies of the implant-tissue interface
32. Ultrastructure of the interface between titanium and surrounding tissue in rat tibiae–a comparison study on titanium-coated and -uncoated plastic implants10.1111/j.1708-8208.2007.00032.x ↗
33. Interactions of collagen types I and II with chondroitin sulfates A-C and their effect on osteoblast adhesion10.1021/bm0609644 ↗
34. Biological functionalization of dental implants with collagen and glycosaminoglycans-A comparative study10.1002/jbm.b.31953 ↗
35. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate10.1016/j.biomaterials.2006.06.034 ↗
36. Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells10.1002/jbm.a.30572 ↗
37. Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes10.1042/bj20030982 ↗
38. Endogenous versus exogenous growth factor regulation of articular chondrocytes10.1002/jor.22444 ↗
39. Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells10.1002/term.1507 ↗
40. Harnessing chondroitin sulphate in composite scaffolds to direct progenitor and stem cell function for tissue repair10.1039/C7BM01158J ↗
41. Nano-scale modification of titanium implant surfaces to enhance osseointegration10.1016/j.actbio.2019.05.045 ↗
42. Nanostructured surface modification to bone implants for bone regeneration10.1166/jbn.2018.2516 ↗